ENTA Financials
Enanta Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$13.51
Market Cap
$328.00M
P/E Ratio
-3.5
EPS
$-3.84
Income Statement Highlights
Most Recent Quarter: 2025-09-30
Revenue
$65.32M
Gross Profit
-
Operating Income
-
Net Income
$-81.89M
EPS (Diluted)
$-3.84
Balance Sheet Highlights
Total Assets
$280.73M
Total Liabilities
$216.01M
Shareholders Equity
-
Cash & Equivalents
$32.30M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-19.27M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-121.6%
Net Margin
-125.4%
ROE
-84.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ENTA revenue?
ENTA's most recent quarterly revenue was $65.32M. Annual revenue can be calculated by summing the four most recent quarters.
Is ENTA profitable?
ENTA reported a loss of $81.89M in the most recent quarter. The net profit margin is -125.4%.
What is ENTA market cap?
ENTA has a market capitalization of $328.00M, making it a small-cap stock.
Does ENTA have debt?
View ENTA's balance sheet for debt information.
What is ENTA cash flow?
Cash flow data is available in the full financial statements.